Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Non Operating Income: 2021-2023

Historic Non Operating Income for Immuneering (IMRX) over the last 3 years, with Dec 2023 value amounting to $1.3 million.

  • Immuneering's Non Operating Income rose 107.97% to $464,352 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year increase of 515.32%. This contributed to the annual value of $1.3 million for FY2023, which is 515.31% up from last year.
  • Per Immuneering's latest filing, its Non Operating Income stood at $1.3 million for FY2023, which was up 515.31% from $216,844 recorded in FY2022.
  • Immuneering's 5-year Non Operating Income high stood at $1.3 million for FY2023, and its period low was -$127,063 during FY2021.
  • For the 3-year period, Immuneering's Non Operating Income averaged around $474,683, with its median value being $216,844 (2022).
  • Data for Immuneering's Non Operating Income shows a peak YoY soared of 515.31% (in 2023) over the last 5 years.
  • Immuneering's Non Operating Income (Yearly) stood at -$127,063 in 2021, then soared by 270.66% to $216,844 in 2022, then soared by 515.31% to $1.3 million in 2023.